Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118464) titled 'Clinical Synergism and Metabolic Mechanism of Rehmannia Leaf Total Glycosides Capsule Combined with Valsartan in the Treatment of Diabetic Nephropathy' on Feb. 5.
Study Type: Interventional study
Study Design:
Non randomized control
Primary Sponsor: Tangshan Traditional Chinese Medicine Hospital
Condition:
Diabetic nephropathy
Intervention:
Control group:Receive the standard Western medicine treatment plan, including regular management of blood sugar, blood pressure and blood lipids: Hypoglycemic treatment: Metformin Hydrochloride (Approval Number: H21022377, Dandong Yichuang Pharmaceutical Co., Ltd., Spec...